Suppr超能文献

相似文献

1
Role of the signal peptide in the synthesis and processing of the glucagon-like peptide-1 receptor.
Br J Pharmacol. 2010 Jan;159(1):237-51. doi: 10.1111/j.1476-5381.2009.00517.x. Epub 2009 Nov 27.
4
Functional consequences of glucagon-like peptide-1 receptor cross-talk and trafficking.
J Biol Chem. 2015 Jan 9;290(2):1233-43. doi: 10.1074/jbc.M114.592436. Epub 2014 Dec 1.
5
Caveolin-1 regulates cellular trafficking and function of the glucagon-like Peptide 1 receptor.
Mol Endocrinol. 2006 Dec;20(12):3400-11. doi: 10.1210/me.2006-0178. Epub 2006 Aug 24.
7
Distinct regions in the C-Terminus required for GLP-1R cell surface expression, activity and internalisation.
Mol Cell Endocrinol. 2015 Sep 15;413:66-77. doi: 10.1016/j.mce.2015.06.012. Epub 2015 Jun 24.
9
A small molecule ligand of the glucagon-like peptide 1 receptor targets its amino-terminal hormone binding domain.
J Biol Chem. 2001 Oct 12;276(41):37787-93. doi: 10.1074/jbc.M106692200. Epub 2001 Aug 9.
10
Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain.
J Biol Chem. 2008 Apr 25;283(17):11340-7. doi: 10.1074/jbc.M708740200. Epub 2008 Feb 20.

引用本文的文献

1
Exploring Therapeutic Strategies: The Relationship between Metabolic Disorders and FOXO Signalling in Alzheimer's Disease.
CNS Neurol Disord Drug Targets. 2025;24(3):196-207. doi: 10.2174/0118715273321002240919102841.
2
Rapid One-Step Capturing of Native, Cell-Free Synthesized and Membrane-Embedded GLP-1R.
Int J Mol Sci. 2023 Feb 1;24(3):2808. doi: 10.3390/ijms24032808.
4
Reagents and models for detecting endogenous GLP1R and GIPR.
EBioMedicine. 2021 Dec;74:103739. doi: 10.1016/j.ebiom.2021.103739. Epub 2021 Dec 12.
5
The Effect of Cell Surface Expression and Linker Sequence on the Recruitment of Arrestin to the GIP Receptor.
Front Pharmacol. 2020 Aug 13;11:1271. doi: 10.3389/fphar.2020.01271. eCollection 2020.
6
The PAR2 signal peptide prevents premature receptor cleavage and activation.
PLoS One. 2020 Feb 20;15(2):e0222685. doi: 10.1371/journal.pone.0222685. eCollection 2020.
7
Glucagon-like peptide 1 (GLP-1).
Mol Metab. 2019 Dec;30:72-130. doi: 10.1016/j.molmet.2019.09.010. Epub 2019 Sep 30.
8
Agonist-induced membrane nanodomain clustering drives GLP-1 receptor responses in pancreatic beta cells.
PLoS Biol. 2019 Aug 20;17(8):e3000097. doi: 10.1371/journal.pbio.3000097. eCollection 2019 Aug.
9
Liraglutide modulates adipokine expression during adipogenesis, ameliorating obesity, and polycystic ovary syndrome in mice.
Endocrine. 2019 May;64(2):349-366. doi: 10.1007/s12020-019-01891-3. Epub 2019 Mar 23.
10
Prediction of Signal Peptides in Proteins from Malaria Parasites.
Int J Mol Sci. 2018 Nov 22;19(12):3709. doi: 10.3390/ijms19123709.

本文引用的文献

2
PKR regulates B56(alpha)-mediated BCL2 phosphatase activity in acute lymphoblastic leukemia-derived REH cells.
J Biol Chem. 2008 Dec 19;283(51):35474-85. doi: 10.1074/jbc.M800951200. Epub 2008 Oct 28.
3
Molecular modeling of the three-dimensional structure of GLP-1R and its interactions with several agonists.
J Mol Model. 2009 Jan;15(1):53-65. doi: 10.1007/s00894-008-0372-2. Epub 2008 Oct 22.
4
Insights into the structural basis of endogenous agonist activation of family B G protein-coupled receptors.
Mol Endocrinol. 2008 Jun;22(6):1489-99. doi: 10.1210/me.2008-0025. Epub 2008 Mar 27.
5
Guide to Receptors and Channels (GRAC), 3rd edition.
Br J Pharmacol. 2008 Mar;153 Suppl 2(Suppl 2):S1-209. doi: 10.1038/sj.bjp.0707746.
6
Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain.
J Biol Chem. 2008 Apr 25;283(17):11340-7. doi: 10.1074/jbc.M708740200. Epub 2008 Feb 20.
7
Biology of incretins: GLP-1 and GIP.
Gastroenterology. 2007 May;132(6):2131-57. doi: 10.1053/j.gastro.2007.03.054.
8
A molecular basis of analgesic tolerance to cannabinoids.
J Neurosci. 2007 Apr 11;27(15):4165-77. doi: 10.1523/JNEUROSCI.5648-06.2007.
9
Mechanisms of action of glucagon-like peptide 1 in the pancreas.
Pharmacol Ther. 2007 Mar;113(3):546-93. doi: 10.1016/j.pharmthera.2006.11.007. Epub 2006 Dec 28.
10
The corticotropin-releasing factor receptor type 2a contains an N-terminal pseudo signal peptide.
J Biol Chem. 2006 Aug 25;281(34):24910-21. doi: 10.1074/jbc.M601554200. Epub 2006 Jun 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验